Systemic inflammation and delirium: Important co-factors in the progression of dementia

Biochemical Society Transactions

Volumn 39, Issue 4, 2011, Pages 945-953

  Cunningham, Colm ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Alzheimer's disease (AD); Animal model; Delirium; Dementia; Microglia; Microglial priming; Systemic inflammation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BETA SECRETASE; DOXYCYCLINE; GAMMA SECRETASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; RIFAMPICIN; SULINDAC; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE ENCEPHALITIS; BRAIN FUNCTION; BRAIN HOMOGENATE; BRAIN ISCHEMIA; COGNITIVE DEFECT; CONFERENCE PAPER; DEATH; DELIRIUM; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; ENCEPHALITIS; ENZYME ACTIVITY; HUMAN; INFLAMMATION; INSTITUTIONALIZATION; LONG TERM POTENTIATION; MAZE TEST; MEMORY CONSOLIDATION; NERVE DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; RISK FACTOR; RISK REDUCTION; TASK PERFORMANCE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CENTRAL NERVOUS SYSTEM; DELIRIUM; DEMENTIA; DISEASE PROGRESSION; HUMANS; INFLAMMATION;

ANIMALIA;

EID: 79960866841     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390945     Document Type: Conference Paper

References (75)

1. McGeer, P.L., McGeer, E., Rogers, J. and Sibley, J. (1990) Anti-inflammatory drugs and Alzheimer disease. Lancet 335, 1037 (Pubitemid 20148621)
2. Aisen, P.S. (2002) The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol. 1, 279-284
3. Martin, B.K., Szekely, C., Brandt, J., Piantadosi, S., Breitner, J.C., Craft, S., Evans, D., Green, R. and Mullan, M. (2008) Cognitive function over time in the Alzheimer's disease anti-inflammatory prevention trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch. Neurol. 65, 896-905
4. Reitz, C., Tang, M.X., Schupf, N., Manly, J.J., Mayeux, R. and Luchsinger, J.A. (2010) A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch. Neurol. 67, 835-841
5. Yaffe, K., Kanaya, A., Lindquist, K., Simonsick, E.M., Harris, T., Shorr, R.I., Tylavsky, F.A. and Newman, A.B. (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA, J. Am. Med. Assoc. 292, 2237-2242
6. American Psychiatry Association (APA) (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn, American Psychiatry Association, Washington, DC
7. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research, WHO, Geneva
8. MacLullich, A.M., Ferguson, K.J., Miller, T., de Rooij, S.E. and Cunningham, C. (2008) Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J. Psychosom. Res. 65, 229-238
9. Inouye, S.K. and Charpentier, P.A. (1996) Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA, J. Am. Med. Assoc. 275, 852-857 (Pubitemid 26087222)
10. Jackson, J.C., Gordon, S.M., Hart, R.P., Hopkins, R.O. and Ely, E.W. (2004) The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol. Rev. 14, 87-98
11. MacLullich, A.M., Beaglehole, A., Hall, R.J. and Meagher, D.J. (2009) Delirium and long-term cognitive impairment. Int. Rev. Psychiatry 21, 30-42
12. Fong, T.G., Jones, R.N., Shi, P., Marcantonio, E.R., Yap, L., Rudolph, J.L., Yang, F.M., Kiely, D.K. and Inouye, S.K. (2009) Delirium accelerates cognitive decline in Alzheimer disease. Neurology 72, 1570-1575
13. Witlox, J., Eurelings, L.S., de Jonghe, J.F., Kalisvaart, K.J., Eikelenboom, P. and van Gool, W.A. (2010) Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA, J. Am. Med. Assoc. 304, 443-451
14. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W. and Kelley, K.W. (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46-56
15. Cunningham, C. and Sanderson, D.J. (2008) Malaise in the water maze: untangling the effects of LPS and IL-1β on learning and memory. Brain Behav. Immun. 22, 1117-1127
16. Betmouni, S., Deacon, R.M.J., Rawlins, J.N.P. and Perry, V.H. (1999) Behavioural consequences of prion disease targeted to the hippocampus in a mouse model of scrapie. Psychobiology 27, 63-71 (Pubitemid 29207307)
17. Betmouni, S., Perry, V.H. and Gordon, J.L. (1996) Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 74, 1-5 (Pubitemid 26291142)
18. Cunningham, C., Deacon, R., Wells, H., Boche, D., Waters, S., Diniz, C.P., Scott, H., Rawlins, J.N. and Perry, V.H. (2003) Synaptic changes characterize early behavioural changes in the ME7 model of murine prion disease. Eur. J. Neurosci. 17, 2147-2155
19. Combrinck, M.I., Perry, V.H. and Cunningham, C. (2002) Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 112, 7-11 (Pubitemid 34603493)
20. Barrientos, R.M., Higgins, E.A., Biedenkapp, J.C., Sprunger, D.B., Wright-Hardesty, K.J., Watkins, L.R., Rudy, J.W. and Maier, S.F. (2006) Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol. Aging 27, 723-732
21. Godbout, J.P., Chen, J., Abraham, J., Richwine, A.F., Berg, B.M., Kelley, K.W. and Johnson, R.W. (2005) Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 19, 1329-1331
22. Cunningham, C., Wilcockson, D.C., Campion, S., Lunnon, K. and Perry, V.H. (2005) Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25, 9275-9284 (Pubitemid 41500836)
23. Field, R., Campion, S., Warren, C., Murray, C. and Cunningham, C. (2010) Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNα/β and IL-1β responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav. Immun. 24, 996-1007
24. Lee, J., Chan, S.L. and Mattson, M.P. (2002) Adverse effect of a Presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain. Neuromol. Med. 2, 29-45
25. Sheng, J.G., Bora, S.H., Xu, G., Borchelt, D.R., Price, D.L. and Koliatsos, V.E. (2003) Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice. Neurobiol. Dis. 14, 133-145
26. Sly, L.M., Krzesicki, R.F., Brashler, J.R., Buhl, A.E., McKinley, D.D., Carter, D.B. and Chin, J.E. (2001) Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease. Brain Res. Bull. 56, 581-588
27. Godoy, M.C., Tarelli, R., Ferrari, C.C., Sarchi, M.I. and Pitossi, F.J. (2008) Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 131, 1880-1894 (Pubitemid 351957456)
28. Villaran, R.F., Espinosa-Oliva, A.M., Sarmiento, M., De Pablos, R.M., Arguelles, S., Delgado-Cortes, M.J., Sobrino, V., Van Rooijen, N., Venero, J.L., Herrera, A.J. et al. (2010) Ulcerative colitis exacerbates lipopolysaccharide- induced damage to the nigral dopaminergic system: potential risk factor in Parkinson's disease. J. Neurochem. 114, 1687-1700
29. McColl, B.W., Rothwell, N.J. and Allan, S.M. (2007) Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 27, 4403-4412 (Pubitemid 46640725)
30. Serres, S., Anthony, D.C., Jiang, Y., Broom, K.A., Campbell, S.J., Tyler, D.J., van Kasteren, S.I., Davis, B.G. and Sibson, N.R. (2009) Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J. Neurosci. 29, 4820-4828
31. Palin, K., Cunningham, C., Forse, P., Perry, V.H. and Platt, N. (2008) Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration. Neurobiol. Dis. 30, 19-29
32. Terrando, N., Monaco, C., Ma, D., Foxwell, B.M., Feldmann, M. and Maze, M. (2010) Tumor necrosis factor-α triggers a cytokine cascade yielding postoperative cognitive decline. Proc. Natl. Acad. Sci. U.S.A. 107, 20518-20522
33. Cibelli, M., Fidalgo, A.R., Terrando, N., Ma, D., Monaco, C., Feldmann, M., Takata, M., Lever, I.J., Nanchahal, J., Fanselow, M.S. and Maze, M. (2010) Role of interleukin-1β in postoperative cognitive dysfunction. Ann. Neurol. 68, 360-368
34. Barrientos, R.M., Higgins, E.A., Sprunger, D.B., Watkins, L.R., Rudy, J.W. and Maier, S.F. (2002) Memory for context is impaired by a post context exposure injection of interleukin-1β into dorsal hippocampus. Behav. Brain Res. 134, 291-298
35. Krenk, L., Rasmussen, L.S. and Kehlet, H. (2010) New insights into the pathophysiology of postoperative cognitive dysfunction. Acta Anaesthesiol. Scand. 54, 951-956
36. van Munster, B.C., Bisschop, P.H., Zwinderman, A.H., Korevaar, J.C., Endert, E., Wiersinga, W.J., Oosten, H.E., Goslings, J.C. and Rooij, S.E. (2010) Cortisol, interleukins and S100B in delirium in the elderly. Brain Cogn. 74, 18-23
37. Maren, S. (2008) Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats. Eur. J. Neurosci. 28, 1661-1666
38. Kohman, R.A., Tarr, A.J., Byler, S.L. and Boehm, G.W. (2007) Age increases vulnerability to bacterial endotoxin-induced behavioral decrements. Physiol. Behav. 91, 561-565
39. Cole, M.G. (2010) Persistent delirium in older hospital patients. Curr. Opin. Psychiatry 23, 250-254
40. Chen, J., Buchanan, J.B., Sparkman, N.L., Godbout, J.P., Freund, G.G. and Johnson, R.W. (2008) Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav. Immun. 22, 301-311
41. Cunningham, C., Campion, S., Lunnon, K., Murray, C.L., Woods, J.F., Deacon, R.M., Rawlins, J.N. and Perry, V.H. (2009) Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry 65, 304-312
42. Murray, C., Sanderson, D.J., Barkus, C., Deacon, R.M., Rawlins, J.N., Bannerman, D.M. and Cunningham, C. (2010) Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. Neurobiol. Aging, doi:10.1016/j.neurobiolaging.2010.04.002
43. 2 elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1β expression. J. Neurochem. 114, 247-258
44. Ashe, K.H. and Zahs, K.R. (2010) Probing the biology of Alzheimer's disease in mice. Neuron 66, 631-645
45. Lee, J.W., Lee, Y.K., Yuk, D.Y., Choi, D.Y., Ban, S.B., Oh, K.W. and Hong, J.T. (2008) Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of β-amyloid generation. J. Neuroinflammation 5, 37
46. Brugg, B., Dubreuil, Y.L., Huber, G., Wollman, E.E., Delhaye-Bouchaud, N. and Mariani, J. (1995) Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. U.S.A. 92, 3032-3035
47. Semmler, A., Frisch, C., Debeir, T., Ramanathan, M., Okulla, T., Klockgether, T. and Heneka, M.T. (2007) Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp. Neurol. 204, 733-740
48. Semmler, A., Hermann, S., Mormann, F., Weberpals, M., Paxian, S.A., Okulla, T., Schafers, M., Kummer, M.P., Klockgether, T. and Heneka, M.T. (2008) Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J. Neuroinflammation 5, 38
49. Weberpals, M., Hermes, M., Hermann, S., Kummer, M.P., Terwel, D., Semmler, A., Berger, M., Schafers, M. and Heneka, M.T. (2009) NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. J. Neurosci. 29, 14177-14184
50. Sharshar, T., Carlier, R., Bernard, F., Guidoux, C., Brouland, J.P., Nardi, O., de la Grandmaison, G.L., Aboab, J., Gray, F., Menon, D. and Annane, D. (2007) Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med. 33, 798-806 (Pubitemid 46675332)
51. Lemstra, A.W., Groen in't Woud, J.C., Hoozemans, J.J., van Haastert, E.S., Rozemuller, A.J., Eikelenboom, P. and van Gool, W.A. (2007) Microglia activation in sepsis: a case-control study. J. Neuroinflammation 4, 4
52. Nguyen, M.D., D'Aigle, T., Gowing, G., Julien, J.P. and Rivest, S. (2004) Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 24, 1340-1349 (Pubitemid 38222984)
53. Kitazawa, M., Oddo, S., Yamasaki, T.R., Green, K.N. and LaFerla, F.M. (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci. 25, 8843-8853 (Pubitemid 41384452)
54. Ebert, S., Goos, M., Rollwagen, L., Baake, D., Zech, W.D., Esselmann, H., Wiltfang, J., Mollenhauer, B., Schliebs, R., Gerber, J. and Nau, R. (2010) Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases. J. Neurosci. Res. 88, 1124-1136
55. Balachandran, S., Kim, C.N., Yeh, W.C., Mak, T.W., Bhalla, K. and Barber, G.N. (1998) Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17, 6888-6902 (Pubitemid 28550283)
56. Jiang, Z., Belforte, J.E., Lu, Y., Yabe, Y., Pickel, J., Smith, C.B., Je, H.S., Lu, B. and Nakazawa, K. (2010) eIF2α phosphorylation-dependent translation in CA1 pyramidal cells impairs hippocampal memory consolidation without affecting general translation. J. Neurosci. 30, 2582-2594
57. Holmes, C. and Lovestone, S. (2003) Long-term cognitive and functional decline in late onset Alzheimer's disease: therapeutic implications. Age Ageing 32, 200-204 (Pubitemid 36372428)
58. Perry, V.H., Cunningham, C. and Holmes, C. (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7, 161-167
59. Holmes, C. and Cotterell, D. (2009) Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs 23, 993-1002
60. Dunn, N., Mullee, M., Perry, V.H. and Holmes, C. (2005) Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis. Assoc. Disord. 19, 91-94
61. Strandberg, T.E., Pitkala, K.H., Linnavuori, K.H. and Tilvis, R.S. (2003) Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke 34, 2126-2131 (Pubitemid 37099824)
62. Strandberg, T.E., Pitkala, K.H., Linnavuori, K. and Tilvis, R.S. (2004) Cognitive impairment and infectious burden in the elderly. Arch. Gerontol. Geriatr. Suppl. 419-423
63. Tilvis, R.S., Kahonen-Vare, M.H., Jolkkonen, J., Valvanne, J., Pitkala, K.H. and Strandberg, T.E. (2004) Predictors of cognitive decline and mortality of aged people over a 10-year period. J. Gerontol. A Biol. Sci. Med. Sci. 59, 268-274
64. Kamer, A.R., Craig, R.G., Pirraglia, E., Dasanayake, A.P., Norman, R.G., Boylan, R.J., Nehorayoff, A., Glodzik, L., Brys, M. and de Leon, M.J. (2009) TNF-α and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J. Neuroimmunol. 216, 92-97
65. Verreault, R., Laurin, D., Lindsay, J. and De Serres, G. (2001) Past exposure to vaccines and subsequent risk of Alzheimer's disease. Can. Med. Assoc. J. 165, 1495-1498
66. Loeb, M.B., Molloy, D., Smieja, M., Standish, T., Goldsmith, C.H., Mahony, J., Smith, S., Borrie, M., Decoteau, E., Davidson, W. et al. (2004) A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease. J. Am. Geriatr. Soc. 52, 381-387
67. Holmes, C., El-Okl, M., Williams, A.L., Cunningham, C., Wilcockson, D. and Perry, V.H. (2003) Systemic infection, interleukin 1β, and cognitive decline in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 74, 788-789
68. Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D. and Perry, V.H. (2009) Systemic inflammation and disease progression in Alzheimer's disease. Neurology 73, 768-774
69. Cole, M., McCusker, J., Dendukuri, N. and Han, L. (2003) The prognostic significance of subsyndromal delirium in elderly medical inpatients. J. Am. Geriatr. Soc. 51, 754-760
70. Jones, C., Griffiths, R.D., Slater, T., Benjamin, K.S. and Wilson, S. (2006) Significant cognitive dysfunction in non-delirious patients identified during and persisting following critical illness. Intensive Care Med. 32, 923-926 (Pubitemid 43781378)
71. Holmes, C., Cunningham, C., Zotova, E., Culliford, D. and Perry, V.H. (2011) Pro-inflammatory cytokines, sickness behavior and Alzheimer's disease. Neurology, in the press
72. Vlad, S.C., Miller, D.R., Kowall, N.W. and Felson, D.T. (2008) Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70, 1672-1677 (Pubitemid 351644133)
73. Laino, C. (2009) In follow-up analysis of clinical trial, NSAIDs seem to preserve cognitive function in patients with healthy brains. Neurol. Today 9, 21-22
74. Chou, R.C. (2010) Anti-TNF therapies for rheumatoid arthritis could reduce Alzheimer's risk. American College of Rheumatology, http://www. rheumatology.org/about/newsroom/2010/2010-anti-tnf -therapies-for-rheumatoid- arthritis-could-reduce-alzheimers-risk.asp
75. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357, 169-175